Analyst Ratings for Verve Therapeutics (VERV)
VERV Rating Summary
VERV Price Target Summary
- Highest: $40.00 (Stifel)
- Lowest: $15.00 (H.C. Wainwright)
- Average: $27.80
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$27.80 (+346.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$27.80 (+346.9%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/8/2024 | H.C. Wainwright | Mitchell Kapoor | New Coverage | Buy (N/A) |
15.00 (N/A) |
8.52 (6.22) |
-27% | Details |
| 4/13/2023 | Canaccord Genuity » Updated 2/28/2024 |
Whitney Ijem | New Coverage | Buy (N/A) |
30.00 (32.00) |
13.69 (6.22) |
-54.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
